Related Experiment Video

Updated: May 9, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1

Rita Fragoso1, Tin Mao, Song Wang

  • 1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.

Plos Genetics
|August 24, 2012
PubMed

Insights

Deleting mir-181a-1/b-1 inhibits Notch1 oncogene-driven T cell acute lymphoblastic leukemia (T-ALL) development. This microRNA selectively targets tumor pathways, offering a potential therapy with minimal toxicity to normal cells.

Area of Science:

  • Molecular biology
  • Cancer research
  • Immunology

Background:

  • Oncogenes are crucial for cancer development and are key therapeutic targets.
  • Targeting oncogene pathways can cause significant toxicity in normal tissues.
  • Notch1 oncogene drives T cell acute lymphoblastic leukemia (T-ALL) development.

Purpose of the Study:

  • To investigate the role of mir-181a-1/b-1 in Notch1 oncogene-induced T-ALL.
  • To determine if mir-181a-1/b-1 can be selectively targeted for cancer therapy.
  • To understand the molecular mechanisms by which mir-181a-1/b-1 regulates Notch signaling.

Main Methods:

  • Gene deletion studies in a mouse model of T-ALL.
  • Analysis of Notch and pre-T cell receptor (TCR) signaling pathways.
  • Comparative analysis of mir-181a-1/b-1 function in normal thymocytes and leukemia cells.

Main Results:

  • Deletion of mir-181a-1/b-1 significantly inhibited T-ALL development.
  • mir-181a-1/b-1 dampens negative feedback regulators downstream of NOTCH and TCR signaling.
  • Targeting mir-181a-1/b-1 inhibited tumor development with minimal toxicity to normal thymocyte development.
  • mir-181a-1/b-1, but not other mir-181 family members, controls both normal T cell and leukemia cell development.

Conclusions:

  • mir-181a-1/b-1 plays a critical role in Notch1 oncogene-driven T-ALL.
  • Targeting mir-181a-1/b-1 represents a promising strategy for selective T-ALL therapy.
  • Understanding mir-181a-1/b-1's regulatory network offers insights into selective oncogene inhibition.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...